Altamira Therapeutics Ltd. (CYTO)
Largest Insider Buys in Sector
CYTO Stock Price History Chart
CYTO Stock Performance
About Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, including OligoPhore and SemaPhore platforms that are in preclinical stage for oligonucleotide and mRNA delivery; AM-125 that is in phase II clinical trial for the intranasal treatment of vertigo; Keyzilen, …
Insider Activity of Altamira Therapeutics Ltd.
Over the last 12 months, insiders at Altamira Therapeutics Ltd. have bought $0 and sold $0 worth of Altamira Therapeutics Ltd. stock.
On average, over the past 5 years, insiders at Altamira Therapeutics Ltd. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,200 shares for transaction amount of $7,860 was made by SCHNITTKER CHRISTOPHER P (Sr. Vice President and CFO) on 2005‑03‑04.
List of Insider Buy and Sell Transactions, Altamira Therapeutics Ltd.
| 2005-03-04 | Sr. Vice President and CFO | 1,200 0.0053% | $6.55 | $7,860 |